Wearable Injectors Market Analysis and Forecast to 2032: By Type (On-Body, Off-Body), Technology (Spring-based, Motor Driven, Rotary Pump, Expanding Battery), Application (Diabetes, Oncology, Cardiovascular Disease), End-use (Clinics, Hospitals, Ambulatory Surgery Centers, Home Care Settings), and Region
The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period.
Drug delivery systems known as wearable injectors attach to the body and automatically administer patients’ prescribed doses at the right moment. Wearable injectors, in contrast to insulin pumps, is a one-time use devices that are comfortably worn on the body while the medication is subcutaneously injected over a pre-programmed period of seconds or hours. They are taken out of the body and conveniently disposed after the entire dose has been injected. The concept of patient centricity and a greater emphasis on human factors in drug delivery design have encouraged the development of such devices.
Global Wearable Injectors Market Scope and Report Structure
| Report Attribute | Details |
|---|---|
| Market Size in 2021 | $5.3 bn |
| Market Size in 2031 | $21.7 bn |
| Growth Rate (2021-31) | 13.3% |
| Historic Period | 2015-2020 |
| Forecast Period | 2022-2031 |
| Base Year | 2021 |
| Segments Covered | Type, Technology, Application, End-use, and Region |
| Key Companies | Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada) |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Trends and Drivers
A growing emphasis on the use of biologics and monoclonal antibodies (mAbs) to treat diseases such as rheumatoid arthritis, cardiovascular disease, and cancer will provide significant growth opportunities for wearable injectors, as these drugs must be administered parenterally (intravenous, subcutaneous, or intramuscular delivery). According to PhRMA (Pharmaceutical Research and Manufacturers of America), 907 biologics were in development in 2013; the number of biologic drugs in development is continuing to grow exponentially, with over 2,700 remedies in development as of mid-2017, more than tripling the 907 in development in 2013. mAb-based biotherapies account for half of the top 100 drugs and are expected to continue to dominate the pharmaceutical market.
Market Restraints and Challenges
Wearable injectors are not reimbursed in a number of developing countries. In India, for example, wearable insulin pumps are not reimbursed, and no specific guidelines for their use are provided on prescription. Patients with Type 1 diabetes in China must pay for insulin pumps and supplies out of pocket. The lack of reimbursement has a direct impact on access to and adoption of wearable injectors, and is thus expected to have a negative impact on market growth in the coming years.
Market Segmentation
The market can be segmented by type, application, end-use and region. By Type, the market can be divided into On-Body and Off-Body. By Technology, the market can be divided into Spring-based, Motor Driven, Rotary Pump, and Expanding Battery. By Application, the market can be divided into Diabetes, Oncology, and Cardiovascular Disease. By End-use, the market can be divided into Clinics, Hospitals, Ambulatory Surgery Centers, and Home Care Settings. By region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Major Players in the Global Wearable Injectors Market
The key players in the market are Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care (US), Sonceboz (Switzerland), Noble (US), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (UK), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (US) among others.
Wearable Injectors Market Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Wearable Injectors Market Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Wearable Injectors Market Market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Wearable Injectors industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Wearable Injectors Market Market along with the current trends and future estimations to depict imminent investment pockets. The overall Wearable Injectors Market industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Wearable Injectors Market Market are also analyzed.
Table of Contents
Chapter 1. Wearable Injectors Market Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation End-use
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Type
3.3. Market Attractiveness Analysis, by Technology
3.4. Market Attractiveness Analysis, by Application
3.5. Market Attractiveness Analysis, by End-use
Chapter 4. Wearable Injectors Market Market Outlook
4.1. Wearable Injectors Market Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Application Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Wearable Injectors Market Market
4.7. Impact of the Russia and Ukraine War on the Wearable Injectors Market Market
4.8. Case Study Analysis
4.9. Pricing Analysis
Chapter 5. Wearable Injectors Market Market, by Type
5.1. Market Overview
5.2. On –Body
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region
5.3. Off Body
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region
Chapter 6. Wearable Injectors Market Market, by Technology
6.1. Market Overview
6.2. Spring Based
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Motor Driven
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Rotary Pump
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
6.5. Expanding Battery
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Size and Forecast, by Region
Chapter 7. Wearable Injectors Market Market, by Application
7.1. Market Overview
7.2. Diabetes
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. Oncology
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Cardiovascular Disease
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Other
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
Chapter 8. Wearable Injectors Market Market, by End-use
8.1. Market Overview
8.2. Clinics
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. Market Size and Forecast, by Region
8.3. Hospitals
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Market Size and Forecast, by Region
8.4. Ambulatory Surgery Centers
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Market Size and Forecast, by Region
8.5. Homecare Settings
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Market Size and Forecast, by Region
8.6. Others
8.6.1. Key Market Trends & Opportunity Analysis
8.6.2. Market Size and Forecast, by Region
8.7. Protein Synthesis Inhibitors
8.7.1. Key Market Trends & Opportunity Analysis
8.7.2. Market Size and Forecast, by Region
Chapter 9. Wearable Injectors Market Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Wearable Injectors Market Market Size and Forecast, by Type
9.2.3. North America Wearable Injectors Market Market Size and Forecast, by Application
9.2.4. North America Wearable Injectors Market Market Size and Forecast, by Technology
9.2.5. North America Wearable Injectors Market Market Size and Forecast, by End-use
9.2.6. North America Wearable Injectors Market Market Size and Forecast, by Country
9.2.7. The U.S.
9.2.7.1. The U.S. Wearable Injectors Market Market Size and Forecast, by Type
9.2.7.2. The U.S. Wearable Injectors Market Market Size and Forecast, by Application
9.2.7.3. The U.S. Wearable Injectors Market Market Size and Forecast, by Technology
9.2.7.4. The U.S. Wearable Injectors Market Market Size and Forecast, by End-use
9.2.8. Canada
9.2.8.1. Canada Wearable Injectors Market Market Size and Forecast, by Type
9.2.8.2. Canada Wearable Injectors Market Market Size and Forecast, by Application
9.2.8.3. Canada Wearable Injectors Market Market Size and Forecast, by Technology
9.2.8.4. Canada Wearable Injectors Market Market Size and Forecast, by End-use
9.2.9. Mexico
9.2.9.1. Mexico Wearable Injectors Market Market Size and Forecast, by Type
9.2.9.2. Mexico Wearable Injectors Market Market Size and Forecast, by Application
9.2.9.3. Mexico Wearable Injectors Market Market Size and Forecast, by Technology
9.2.9.4. Mexico Wearable Injectors Market Market Size and Forecast, by End-use
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Wearable Injectors Market Market Size and Forecast, by Type
9.3.3. Europe Wearable Injectors Market Market Size and Forecast, by Application
9.3.4. Europe Wearable Injectors Market Market Size and Forecast, by Technology
9.3.5. Europe Wearable Injectors Market Market Size and Forecast, by End-use
9.3.6. Europe Wearable Injectors Market Market Size and Forecast, by Country
9.3.7. The U.K.
9.3.7.1. The U.K. Wearable Injectors Market Market Size and Forecast, by Type
9.3.7.2. The U.K. Wearable Injectors Market Market Size and Forecast, by Application
9.3.7.3. The U.K. Wearable Injectors Market Market Size and Forecast, by Technology
9.3.7.4. The U.K. Wearable Injectors Market Market Size and Forecast, by End-use
9.3.8. Germany
9.3.8.1. Germany Wearable Injectors Market Market Size and Forecast, by Type
9.3.8.2. Germany Wearable Injectors Market Market Size and Forecast, by Application
9.3.8.3. Germany Wearable Injectors Market Market Size and Forecast, by Technology
9.3.8.4. Germany Wearable Injectors Market Market Size and Forecast, by End-use
9.3.9. France
9.3.9.1. France Wearable Injectors Market Market Size and Forecast, by Type
9.3.9.2. France Wearable Injectors Market Market Size and Forecast, by Application
9.3.9.3. France Wearable Injectors Market Market Size and Forecast, by Technology
9.3.9.4. France Wearable Injectors Market Market Size and Forecast, by End-use
9.3.10. Spain
9.3.10.1. Spain Wearable Injectors Market Market Size and Forecast, by Type
9.3.10.2. Spain Wearable Injectors Market Market Size and Forecast, by Application
9.3.10.3. Spain Wearable Injectors Market Market Size and Forecast, by Technology
9.3.10.4. Spain Wearable Injectors Market Market Size and Forecast, by End-use
9.3.11. Italy
9.3.11.1. Italy Wearable Injectors Market Market Size and Forecast, by Type
9.3.11.2. Italy Wearable Injectors Market Market Size and Forecast, by Application
9.3.11.3. Italy Wearable Injectors Market Market Size and Forecast, by Technology
9.3.11.4. Italy Wearable Injectors Market Market Size and Forecast, by End-use
9.3.12. Netherlands
9.3.12.1. Netherlands Wearable Injectors Market Market Size and Forecast, by Type
9.3.12.2. Netherlands Wearable Injectors Market Market Size and Forecast, by Application
9.3.12.3. Netherlands Wearable Injectors Market Market Size and Forecast, by Technology
9.3.12.4. Netherlands Wearable Injectors Market Market Size and Forecast, by End-use
9.3.13. Sweden
9.3.13.1. Sweden Wearable Injectors Market Market Size and Forecast, by Type
9.3.13.2. Sweden Wearable Injectors Market Market Size and Forecast, by Application
9.3.13.3. Sweden Wearable Injectors Market Market Size and Forecast, by Technology
9.3.13.4. Sweden Wearable Injectors Market Market Size and Forecast, by End-use
9.3.14. Switzerland
9.3.14.1. Switzerland Wearable Injectors Market Market Size and Forecast, by Type
9.3.14.2. Switzerland Wearable Injectors Market Market Size and Forecast, by Application
9.3.14.3. Switzerland Wearable Injectors Market Market Size and Forecast, by Technology
9.3.14.4. Switzerland Wearable Injectors Market Market Size and Forecast, by End-use
9.3.15. Denmark
9.3.15.1. Denmark Wearable Injectors Market Market Size and Forecast, by Type
9.3.15.2. Denmark Wearable Injectors Market Market Size and Forecast, by Application
9.3.15.3. Denmark Wearable Injectors Market Market Size and Forecast, by Technology
9.3.15.4. Denmark Wearable Injectors Market Market Size and Forecast, by End-use
9.3.16. Finland
9.3.16.1. Finland Wearable Injectors Market Market Size and Forecast, by Type
9.3.16.2. Finland Wearable Injectors Market Market Size and Forecast, by Application
9.3.16.3. Finland Wearable Injectors Market Market Size and Forecast, by Technology
9.3.16.4. Finland Wearable Injectors Market Market Size and Forecast, by End-use
9.3.17. Russia
9.3.17.1. Russia Wearable Injectors Market Market Size and Forecast, by Type
9.3.17.2. Russia Wearable Injectors Market Market Size and Forecast, by Application
9.3.17.3. Russia Wearable Injectors Market Market Size and Forecast, by Technology
9.3.17.4. Russia Wearable Injectors Market Market Size and Forecast, by End-use
9.3.18. Rest of Europe
9.3.18.1. Rest of Europe Wearable Injectors Market Market Size and Forecast, by Type
9.3.18.2. Rest of Europe Wearable Injectors Market Market Size and Forecast, by Application
9.3.18.3. Rest of Europe Wearable Injectors Market Market Size and Forecast, by Technology
9.3.18.4. Rest of Europe Wearable Injectors Market Market Size and Forecast, by End-use
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Wearable Injectors Market Market Size and Forecast, by Country
9.4.3. Asia-Pacific Wearable Injectors Market Market Size and Forecast, by Type
9.4.4. Asia-Pacific Wearable Injectors Market Market Size and Forecast, by Application
9.4.5. Asia-Pacific Wearable Injectors Market Market Size and Forecast, by Technology
9.4.6. Asia-Pacific Wearable Injectors Market Market Size and Forecast, by End-use
9.4.7. China
9.4.7.1. China Wearable Injectors Market Market Size and Forecast, by Type
9.4.7.2. China Wearable Injectors Market Market Size and Forecast, by Application
9.4.7.3. China Wearable Injectors Market Market Size and Forecast, by Technology
9.4.7.4. China Wearable Injectors Market Market Size and Forecast, by End-use
9.4.8. India
9.4.8.1. India Wearable Injectors Market Market Size and Forecast, by Type
9.4.8.2. India Wearable Injectors Market Market Size and Forecast, by Application
9.4.8.3. India Wearable Injectors Market Market Size and Forecast, by Technology
9.4.8.4. India Wearable Injectors Market Market Size and Forecast, by End-use
9.4.9. Japan
9.4.9.1. Japan Wearable Injectors Market Market Size and Forecast, by Type
9.4.9.2. Japan Wearable Injectors Market Market Size and Forecast, by Application
9.4.9.3. Japan Wearable Injectors Market Market Size and Forecast, by Technology
9.4.9.4. Japan Wearable Injectors Market Market Size and Forecast, by End-use
9.4.10. South Korea
9.4.10.1. South Korea Wearable Injectors Market Market Size and Forecast, by Type
9.4.10.2. South Korea Wearable Injectors Market Market Size and Forecast, by Application
9.4.10.3. South Korea Wearable Injectors Market Market Size and Forecast, by Technology
9.4.10.4. South Korea Wearable Injectors Market Market Size and Forecast, by End-use
9.4.11. Australia
9.4.11.1. Australia Wearable Injectors Market Market Size and Forecast, by Type
9.4.11.2. Australia Wearable Injectors Market Market Size and Forecast, by Application
9.4.11.3. Australia Wearable Injectors Market Market Size and Forecast, by Technology
9.4.11.4. Australia Wearable Injectors Market Market Size and Forecast, by End-use
9.4.12. Singapore
9.4.12.1. Singapore Wearable Injectors Market Market Size and Forecast, by Type
9.4.12.2. Singapore Wearable Injectors Market Market Size and Forecast, by Application
9.4.12.3. Singapore Wearable Injectors Market Market Size and Forecast, by Technology
9.4.12.4. Singapore Wearable Injectors Market Market Size and Forecast, by End-use
9.4.13. Indonesia
9.4.13.1. Indonesia Wearable Injectors Market Market Size and Forecast, by Type
9.4.13.2. Indonesia Wearable Injectors Market Market Size and Forecast, by Application
9.4.13.3. Indonesia Wearable Injectors Market Market Size and Forecast, by Technology
9.4.13.4. Indonesia Wearable Injectors Market Market Size and Forecast, by End-use
9.4.14. Taiwan
9.4.14.1. Taiwan Wearable Injectors Market Market Size and Forecast, by Type
9.4.14.2. Taiwan Wearable Injectors Market Market Size and Forecast, by Application
9.4.14.3. Taiwan Wearable Injectors Market Market Size and Forecast, by Technology
9.4.14.4. Taiwan Wearable Injectors Market Market Size and Forecast, by End-use
9.4.15. Malaysia
9.4.15.1. Malaysia Wearable Injectors Market Market Size and Forecast, by Type
9.4.15.2. Malaysia Wearable Injectors Market Market Size and Forecast, by Application
9.4.15.3. Malaysia Wearable Injectors Market Market Size and Forecast, by Technology
9.4.15.4. Malaysia Wearable Injectors Market Market Size and Forecast, by End-use
9.4.16. Rest of APAC
9.4.16.1. Rest of APAC Wearable Injectors Market Market Size and Forecast, by Type
9.4.16.2. Rest of APAC Wearable Injectors Market Market Size and Forecast, by Application
9.4.16.3. Rest of APAC Wearable Injectors Market Market Size and Forecast, by Technology
9.4.16.4. Rest of APAC Wearable Injectors Market Market Size and Forecast, by End-use
9.5. Rest of The World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of The World Wearable Injectors Market Market Size and Forecast, by Type
9.5.3. Rest of The World Wearable Injectors Market Market Size and Forecast, by Application
9.5.4. Rest of The World Wearable Injectors Market Market Size and Forecast, by Technology
9.5.5. Rest of The World Wearable Injectors Market Market Size and Forecast, by End-use
9.5.6. Rest of The World Wearable Injectors Market Market Size and Forecast, by Country
9.5.7. Latin America
9.5.7.1. Latin America Wearable Injectors Market Market Size and Forecast, by Type
9.5.7.2. Latin America Wearable Injectors Market Market Size and Forecast, by Application
9.5.7.3. Latin America Wearable Injectors Market Market Size and Forecast, by Technology
9.5.7.4. Latin America Wearable Injectors Market Market Size and Forecast, by End-use
9.5.8. Middle East
9.5.8.1. Middle East Wearable Injectors Market Market Size and Forecast, by Type
9.5.8.2. Middle East Wearable Injectors Market Market Size and Forecast, by Application
9.5.8.3. Middle East Wearable Injectors Market Market Size and Forecast, by Technology
9.5.8.4. Middle East Wearable Injectors Market Market Size and Forecast, by End-use
9.5.9. Africa
9.5.9.1. Africa Wearable Injectors Market Market Size and Forecast, by Type
9.5.9.2. Africa Wearable Injectors Market Market Size and Forecast, by Application
9.5.9.3. Africa Wearable Injectors Market Market Size and Forecast, by Technology
9.5.9.4. Africa Wearable Injectors Market Market Size and Forecast, by End-use
Chapter 10. Competitive Landscape
10.1. Market Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Developmental Strategy Benchmarking
10.3.1. New Type Development
10.3.2. Type Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Joint Ventures, And Collaborations
10.3.5. Mergers And Acquisitions
Chapter 11. Company Profiles
11.1. Ypsomed (Switzerland)
11.1.1. Company snapshot
11.1.2. Financial performance
11.1.3. Type offerings
11.1.4. Key strategic initiatives
11.1.5. SWOT analysis
11.2. Amgen (US)
11.2.1. Company snapshot
11.2.2. Financial performance
11.2.3. Type offerings
11.2.4. Key strategic initiatives
11.2.5. SWOT analysis
11.3. Subcuject (Denmark)
11.3.1. Company snapshot
11.3.2. Financial performance
11.3.3. Type offerings
11.3.4. Key strategic initiatives
11.3.5. SWOT analysis
11.4. Enable Injections (US)
11.4.1. Company snapshot
11.4.2. Financial performance
11.4.3. Type offerings
11.4.4. Key strategic initiatives
11.4.5. SWOT analysis
11.5. Medtronic plc (Ireland)
11.5.1. Company snapshot
11.5.2. Financial performance
11.5.3. Type offerings
11.5.4. Key strategic initiatives
11.5.5. SWOT analysis
11.6. Insulet Corporation (US)
11.6.1. Company snapshot
11.6.2. Financial performance
11.6.3. Type offerings
11.6.4. Key strategic initiatives
11.6.5. SWOT analysis
11.7. United Therapeutics Corp. (US)
11.7.1. Company snapshot
11.7.2. Financial performance
11.7.3. Type offerings
11.7.4. Key strategic initiatives
11.7.5. SWOT analysis
11.8. CeQur SA (Switzerland)
11.8.1. Company snapshot
11.8.2. Financial performance
11.8.3. Type offerings
11.8.4. Key strategic initiatives
11.8.5. SWOT analysis
11.9. Sensile Medical (Switzerland)
11.9.1. Company snapshot
11.9.2. Financial performance
11.9.3. Type offerings
11.9.4. Key strategic initiatives
11.9.5. SWOT analysis
11.10. ATS Automation (Canada)
11.10.1. Company snapshot
11.10.2. Financial performance
11.10.3. Type offerings
11.10.4. Key strategic initiatives
11.10.5. SWOT analysis
11.11. West Pharmaceutical Services, Inc. (US)
11.11.1. Company snapshot
11.11.2. Financial performance
11.11.3. Type offerings
11.11.4. Key strategic initiatives
11.11.5. SWOT analysis
11.12. Tandem Diabetes Care (US)
11.12.1. Company snapshot
11.12.2. Financial performance
11.12.3. Type offerings
11.12.4. Key strategic initiatives
11.12.5. SWOT analysis
11.13. Valeritas (US)
11.13.1. Company snapshot
11.13.2. Financial performance
11.13.3. Type offerings
11.13.4. Key strategic initiatives
11.13.5. SWOT analysis
11.14. Sonceboz (Switzerland)
11.14.1. Company snapshot
11.14.2. Financial performance
11.14.3. Type offerings
11.14.4. Key strategic initiatives
11.14.5. SWOT analysis
11.15. Noble (US)
11.15.1. Company snapshot
11.15.2. Financial performance
11.15.3. Type offerings
11.15.4. Key strategic initiatives
11.15.5. SWOT analysis
11.16. Elcam Drug Delivery Devices (Israel)
11.16.1. Company snapshot
11.16.2. Financial performance
11.16.3. Type offerings
11.16.4. Key strategic initiatives
11.16.5. SWOT analysis
11.17. Bespak Europe Ltd. (UK)
11.17.1. Company snapshot
11.17.2. Financial performance
11.17.3. Type offerings
11.17.4. Key strategic initiatives
11.17.5. SWOT analysis
11.18. Stevanato Group (Italy)
11.18.1. Company snapshot
11.18.2. Financial performance
11.18.3. Type offerings
11.18.4. Key strategic initiatives
11.18.5. SWOT analysis
11.19. Sorrel Medical (Israel)
11.19.1. Company snapshot
11.19.2. Financial performance
11.19.3. Type offerings
11.19.4. Key strategic initiatives
11.19.5. SWOT analysis
11.20. Weibel CDS AG (Switzerland)
11.20.1. Company snapshot
11.20.2. Financial performance
11.20.3. Type offerings
11.20.4. Key strategic initiatives
11.20.5. SWOT analysis
11.21. Neuma (US)
11.21.1. Company snapshot
11.21.2. Financial performance
11.21.3. Type offerings
11.21.4. Key strategic initiatives
11.21.5. SWOT analysis
*the list of company is subject to change during the final compilation of the report
Key Players
- Ypsomed (Switzerland)
- Amgen (US)
- Subcuject (Denmark)
- Enable Injections (US)
- Medtronic plc (Ireland)
- Insulet Corporation (US)
- United Therapeutics Corp. (US)
- CeQur SA (Switzerland)
- Sensile Medical (Switzerland)
- ATS Automation (Canada)
- West Pharmaceutical Services, Inc. (US)
- Tandem Diabetes Care (US)
- Sonceboz (Switzerland)
- Noble (US)
- Elcam Drug Delivery Devices (Israel)
- Bespak Europe Ltd. (UK)
- Stevanato Group (Italy)
- Sorrel Medical (Israel)
- Weibel CDS AG (Switzerland)
- Neuma (US)
Market Segments
By Type
- On-Body
- Off-Body
By Technology
- Spring-based
- Motor Driven
- Rotary Pump
- Expanding Battery
By Application
- Diabetes
- Oncology
- Cardiovascular Disease
- Others
By End-use
- Clinics
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa